CLC Number:
- R473.73
| [1] 中国临床肿瘤学会免疫治疗专家委员会,中国临床肿瘤学会抗肿瘤药物安全管理专家委员会.免疫检查点抑制剂相关的毒性多学科诊疗协作组建设中国专家共识[J].临床肿瘤学杂志,2022,27(2):158-164. [2] 王艳,何瑞仙,翟敏锋,等.84例肺癌患者应用程序性死亡蛋白-1的免疫不良反应及护理[J].护理学报, 2021,28(10):67-69.DOI:10.16460/j.issn1008-9969.2021.10.067. [3] 张一清,穆银玉,马晶晶,等.9例肺腺癌患者应用PD1/PDL1抑制剂行超适应证治疗的护理[J].护理学报,2019,26(11):74-75.DOI:10.16460/j.issn1008-9969.2019.11.074. [4] Wang Y, Zhou S, Yang F, et al.Treatment-related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis[J]. JAMA Oncol, 2019,5(7):1008-1019. DOI:10.1001/jamaoncol.2019.0393. [5] Rau KM, Shun SC, Chiou TJ, et al.A nationwide Survey of Fatigue in Cancer Patients in Taiwan: An Unmet Need[J]. Jpn J Clin Oncol, 2020,50(6):693-700. DOI:10.1093/jjco/hyaa038. [6] 张云,周爽,李榕.质量管理在药物临床试验免疫治疗中的作用分析[J].中国临床药理学杂志, 2020,36(22):3811-3813;3822.DOI:10.13699/j.cnki.1001-6821.2020.22.056. [7] Thompson JA,Schneider BJ,Brahmer J,et al.NCCN Guidelines Insights: Management of Immunotherapy-related Toxicities, Version 1.2020[J]. J Natl Compr Canc Netw, 2020,18(3):230-241. DOI:10.6004/jnccn.2020.0012. [8] Dodd M, Janson S, Facione N, et al.Advancing the Science of Symptom Management[J]. J Adv Nurs, 2001,33(5):668-676. DOI:10.1046/j.1365-2648.2001.01697.x. [9] 夏露. 基于循证和德尔菲法构建鼻咽癌放疗患者张口困难的预防方案[D].合肥:安徽医科大学,2020.DOI:10.26921/d.cnki.ganyu.2020.001118. [10] 袁美玲,高玉芳,尚丹丹,等. ICU方向护理硕士专业学位研究生培养方案的构建[J]. 中华护理教育, 2020,17(3):232-236. DOI:10.3761/j.issn.1672-9234.2020.03.009. [11] 熊照玉,李素云,杨赛,等.构建住院患者肠内营养相关便秘预警分级标准及干预方案[J].护理学报,2021,28(17):70-75.DOI:10.16460/j.issn1008-9969.2021.17.070. [12] 刘美华,彭剑雄,朱丽辉,等.儿科护士健康教育素养评价指标体系的构建[J].护理学报,2021,28(23):69-73.DOI:10.16460/j.issn1008-9969.2021.23.069. [13] McPherson S, Reese C, Wendler MC. Methodology Update: Delphi Studies[J]. Nurs Res, 2018,67(5):404-410. DOI:10.1097/NNR.0000000000000297. [14] Mathew A, Doorenbos AZ, Vincent C.Symptom Management Theory: Analysis, Evaluation, and Implications for Caring for Adults With Cancer[J].ANS Adv Nurs Sci, 2021,44(3):E93-E112. DOI:10.1097/ANS.0000000000000347. [15] Climent-Sanz C, Gea-Sánchez M, Fernández-Lago H, et al.Sleeping Is a Nightmare: A Qualitative Study on the Experience and Management of Poor Sleep Quality in Women with Fibromyalgia[J]. J Adv Nurs, 2021,77(11):4549-4562. DOI:10.1111/jan.14977. [16] 陈伟娟,赵海燕,孔冬,等.成年肿瘤患者癌因性疲乏筛查与评估的证据总结[J].护理学报,2020,27(14):20-25.DOI:10.16460/j.issn1008-9969.2020.14.020. [17] 张剑军,钱建新.中国癌症相关性疲乏临床实践诊疗指南(2021年版)[J].中国癌症杂志,2021,31(9):852-872.DOI:10.19401/j.cnki.1007-3639.2021.09.012. [18] 田利,李惠玲,陶敏,等.《成人癌因性疲乏临床护理指南》的构建研究[J]. 护理研究,2017,31(13):1564-1568. DOI:10.3969/j.issn.1009-6493.2017.13.008. [19] Fabi A, Bhargava R, Fatigoni S, et al.Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment[J]. Ann Oncol, 2020,31(6):713-723. DOI:10.1016/j.annonc.2020.02.016. [20] Palmieri DJ, Carlino MS.Immune Checkpoint Inhibitor Toxicity[J]. Curr Oncol Rep, 2018,20(9):72. DOI:10.1007/s11912-018-0718-6. [21] Brahmer JR, Abu-Sbeih H, Ascierto PA, et al.Society for Immunotherapy of Cancer (SITC) Clinical Practice Guideline on Immune Checkpoint Inhibitor-related Adverse Events[J]. J Immunother Cancer, 2021,9(6):e002435. DOI:10.1136/jitc-2021-002435. [22] McGettigan S, Rubin KM. PD-1 Inhibitor Therapy: Consensus Statement from the Faculty of the Melanoma Nursing Initiative on Managing Adverse Events[J]. Clin J Oncol Nurs, 2017,21(4):42-51. DOI:10.1188/17.CJON.S4.42-51. |
| [1] | CAO Min, ZHANG Pei-li, HOU Xiao-ya, GAO Chao-yue, GUO Lin-fang, LI Ying. Nutritional care experience of caregivers of colorectal cancer patients undergoing chemotherapy based on ABC-X model: a qualitative study [J]. Journal of Nursing, 2025, 32(2): 13-18. |
| [2] | LIU Qi, LIU Jia-li, LIU Yu, YANG Li-min, FAN Yu-ying, LV Xing, JIN Hui-ying. Physical-psychological symptom burden trajectories and influencing factors in nasopharyngeal carcinoma patients during induction chemotherapy plus concurrent chemoradiotherapy [J]. Journal of Nursing, 2025, 32(1): 1-6. |
| [3] | . [J]. Journal of Nursing, 2025, 32(1): 39-43. |
| [4] | YAO Wan-qing, YANG Li-zhuang, CHEN Dan-dan, ZHANG Wan-qiu, LU Wei, GUAN Cui-hong, LI Hai. Efficacy of different non-drug interventions on cancer-related fatigue in breast cancer patients: a network Meta-analysis [J]. Journal of Nursing, 2024, 31(24): 37-43. |
| [5] | DAI Qian, LIU Xiang-yu, ZHU Xiao-mei, WANG Jia-li, HUANG Yuan-si. Status quo of self-compassion in patients with colorectal cancer stoma and its influencing factors [J]. Journal of Nursing, 2024, 31(23): 13-17. |
| [6] | . [J]. Journal of Nursing, 2024, 31(22): 73-78. |
| [7] | LI Yue-ge, KONG Han, CAO Ding, LI Jia-xin, SHANG Ya-meng, CHANG Shu-ying. Current status of fear of cancer recurrence in young and middle-aged patients with cervical cancer after surgery and its influencing factors: a 228-case study [J]. Journal of Nursing, 2024, 31(20): 8-12. |
| [8] | . [J]. Journal of Nursing, 2024, 31(20): 19-23. |
| [9] | . [J]. Journal of Nursing, 2024, 31(20): 29-32. |
| [10] | . [J]. Journal of Nursing, 2024, 31(18): 30-34. |
| [11] | GENG Yu-fang, QIN Ru-meng, WANG Hui, ZHANG Shan-shan, ZHOU Li-hua. Construction of post-traumatic growth model of ovarian cancer patients based on interpretative phenomenological analysis [J]. Journal of Nursing, 2024, 31(18): 73-78. |
| [12] | . [J]. Journal of Nursing, 2024, 31(17): 51-56. |
| [13] | YU Feng, SUN Li, HU De-ying, HU Jie, WANG Jia-qing, LV Chu-feng. Competency model of suicide gatekeeper for oncology nurses based on behavioral event interview and expert consultation [J]. Journal of Nursing, 2024, 31(17): 73-78. |
| [14] | . [J]. Journal of Nursing, 2024, 31(16): 56-61. |
| [15] | ZHANG Shu-zhen, YU Wen-ru, ZHANG Jun-feng, JIANG Jia-yao, LUO Mei, LIN Bi-yu, MAI Min-wen, YANG Meng-ting. Evidence-based nursing practice in prevention and management of radiation dermatitis in cancer patients undergoing radiotherapy [J]. Journal of Nursing, 2024, 31(16): 62-66. |
|
||